DCRI Fellow Jennifer Rymer, MD, MBA, discusses the potential benefits and drawbacks of high-sensitivity troponin, a new assay used to rule out heart attacks or myocardial infarction. See more DCRI studies and results from ACC.19: [ Ссылка ]
![](https://i.ytimg.com/vi/WZo_YCB62-o/maxresdefault.jpg)
DCRI Fellow Jennifer Rymer, MD, MBA, discusses the potential benefits and drawbacks of high-sensitivity troponin, a new assay used to rule out heart attacks or myocardial infarction. See more DCRI studies and results from ACC.19: [ Ссылка ]